Navigation Links
New Pleio Medication Adherence Service Increases Prescription Refills Up To 53%
Date:4/28/2009

Pleio GoodStart(tm) improves compliance and persistence with chronic medications. Prescription refills increase up to 53% during patients' first 100 days of therapy. New free service offers coaching, reminders and pharmacist support to alleviate stress and confusion some patients experience while adopting a newly - prescribed medication.

Philadelphia, PA (PRWEB) April 28, 2009 -- Pleio Health Support Systems, Inc. (Pleio) announces early results of Pleio GoodStart™, the free medication adherence service. Prescription refill data revealed that Pleio's combination of customized medication reminders, phone-based coaching sessions and pharmacist counseling improves prescription refill activity by up to 53%. Data shows a 14% increase in the first prescription refilled, building to a 53% improvement by the third refill. Refill behavior data from 2,850 patients was compiled and analyzed by Pleio.

"For many people, adapting to a new prescription can be stressful and confusing. Adherence to medication is a process that takes time - and patients welcome the 100 days of free support that Pleio provides. The 53% Rx refill improvement suggests that Pleio's sustained, customized patient adherence support works. The medication adherence community will welcome these real-world results," said Jean Lalonde, Co-Chief Executive Officer of Pleio.

Pleio GoodStart connects patients with specially-trained pharmacists via the Outcomes Pharmaceutical Health Care® Personal Pharmacist Network. "Pleio GoodStart supports pharmacists in delivering greater value to their patients while improving medication outcomes," said Patty Kumbera, Chief Operating Officer of Outcomes Pharmaceutical Health Care. The service is now available to over 20,000 pharmacies in the Outcomes Personal Pharmacist Network.

About Pleio:
Pleio Health Supports Systems, founded in 2006, has offices in Montreal and Boston. Pleio GoodStart is a sponsored and free adherence service that improves prescription refills by up to 53%. Pleio GoodStart™ is a registered trademark of Pleio Health Support Systems, Inc. For more information, visit Pleio or contact Jean Lalonde, at (514) 369-9995 (info (at)pleio (dot) com).

About Outcomes Pharmaceutical Health Care:
Outcomes Pharmaceutical Health Care is the national leader in the design, delivery, and administration of Medication Therapy Management programs. The company's service line benefits health care purchasers by delivering a cost effective approach to advancing patient care and controlling utilization through the provision of patient-friendly, face-to-face personal pharmacist services. The company is headquartered in Des Moines, Iowa and may be found online at Outcomes.

###

Read the full story at http://www.prweb.com/releases/2009/04/prweb2361584.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Drug Interaction Tool Offered Free in Response to Increasing At-Home Deaths From Medication Errors
2. Family Medicine Cabinet: Free, New On-Line Tool Helps Track Your Medication Safety
3. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
4. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
5. Prominent Physician Achieves Success Using Topical Sinus Medications via Pulsitile Irrigation
6. Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedixs Med-eXpert(TM) System
7. InnovationRx, a Prescription Adherence Solutions Company, and InforMedix Partner to Market and Sell End-to-End Medication Adherence Solutions
8. Artromick Aligns with McKesson to Enhance Medication Safety at the Patients Bedside
9. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
10. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD)
11. FDA Approves Administration of LEXIVA(R) with Lower Dose of Boosting Medication Ritonavir
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology:
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
(Date:3/22/2016)... 2016 According to ... for Consumer Industry by Type (Image, Motion, Pressure, ... & IT, Entertainment, Home Appliances, & Wearable ... 2022", published by MarketsandMarkets, the market for ... USD 26.76 Billion by 2022, at a ...
Breaking Biology News(10 mins):